Finance

Lists
Q3 2026 earnings • 12:00 AM tomorrow
See details
HIMS:NYSE
Hims & Hers Health Inc
US$26.00
+8.06%
(+1.94) 1D
ኖቬም 6, 4:00:05 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
US$25.78
High
US$26.24
Low
US$24.40
Mkt. cap
6.07 ቢ
Avg. vol.
10.10 ሚ
Volume
0.00
52-wk high
US$42.70
52-wk low
US$13.74
EPS
-US$0.63
Beta
2.53
Shares outstanding
224.94 ሚ
No. of employees
2 ሺ
Open
US$25.78
High
US$26.24
Low
US$24.40
Mkt. cap
6.07 ቢ
Avg. vol.
10.10 ሚ
Volume
0.00
52-wk high
US$42.70
52-wk low
US$13.74
EPS
-US$0.63
Beta
2.53
Shares outstanding
224.94 ሚ
No. of employees
2 ሺ
News stories
From web sources and news partners
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees2.44 ሺ
Foundedኖቬም 2017
Headquartersሳን ፍራንሲስኰ, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryHealth care provider
Website-
Analyst ratings
Based on 14 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
11
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current US$26.00
US$42.00 (+61.54%)
Average
US$32.82 (+26.23%)
Lowest
US$26.00 (0.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Hold
Maintained
US$32.00
+23.1%
11/06/2026
Glen Santangelo
Barclays
Buy
Maintained
US$35.00
+34.6%
10/29/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
US$32.00
+23.1%
09/11/2026
Bryan Smilek
J.P. Morgan
Hold
Initiated
US$32.00
+23.1%
09/11/2026
Brian Tanquilut
Jefferies
Hold
Maintained
US$31.00
+19.2%
09/03/2026
Justin Patterson
KeyBanc
Hold
Maintained
-
-
09/02/2026
George Hill
Deutsche Bank
Hold
Reiterated
US$26.00
0%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
US$30.00
+15.4%
08/11/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
US$28.00
+7.7%
08/11/2026
Maria Ripps
Canaccord Genuity
Buy
Reiterated
US$40.00
+53.8%
08/11/2026
Ryan MacDonald
Needham
Buy
Reiterated
US$42.00
+61.5%
08/11/2026
David Larsen
BTIG
Hold
Reiterated
-
-
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
US$33.00
+26.9%
08/12/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
-
-
08/11/2026
Oliver Chen
TD Cowen
Hold
Reiterated
US$25.00
-3.8%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
US$33.00
+26.9%
05/12/2026
Michael Cherny
Leerink Partners
Hold
Maintained
-
-
04/16/2026
Unknown Analyst
Nephron
Buy
Upgraded
US$35.00
+34.6%
03/09/2026
Next call in 16:48:33
Tomorrow, 12:00 ጥዋት
Fiscal period
Q3 2026
- / US$0.15
Revenue / Est. (USD)
- / 892.77 ሚ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
598.98 ሚ
617.82 ሚ
608.10 ሚ
753.21 ሚ
Cost of goods sold
156.92 ሚ
173.38 ሚ
182.82 ሚ
272.41 ሚ
Cost of revenue
156.92 ሚ
173.38 ሚ
182.82 ሚ
272.41 ሚ
Research and development expenses
40.58 ሚ
40.96 ሚ
46.94 ሚ
54.90 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
389.67 ሚ
386.64 ሚ
426.37 ሚ
521.95 ሚ
Operating expense
430.25 ሚ
427.60 ሚ
473.31 ሚ
576.85 ሚ
Total operating expenses
587.17 ሚ
600.99 ሚ
656.13 ሚ
849.26 ሚ
Operating income
11.81 ሚ
16.83 ሚ
-48.02 ሚ
-96.04 ሚ
Other non operating income
-5.99 ሚ
-575.00 ሺ
-18.58 ሚ
-2.43 ሚ
EBT including unusual items
12.22 ሚ
18.35 ሚ
-101.55 ሚ
-92.63 ሚ
EBT excluding unusual items
12.22 ሚ
21.56 ሚ
-61.57 ሚ
-96.22 ሚ
Income tax expense
-3.55 ሚ
-2.25 ሚ
-9.44 ሚ
-6.34 ሚ
Effective tax rate
-29.05%
-12.25%
9.29%
6.85%
Other operating expenses
-
-
-
-
Net income
15.77 ሚ
20.60 ሚ
-92.12 ሚ
-86.29 ሚ
Net profit margin
2.63%
3.33%
-15.15%
-11.46%
Earnings per share
0.28
0.22
-0.19
-0.09
Interest and investment income
8.01 ሚ
6.80 ሚ
7.90 ሚ
6.00 ሚ
Interest expense
-1.60 ሚ
-1.50 ሚ
-2.87 ሚ
-3.75 ሚ
Net interest expenses
6.41 ሚ
5.30 ሚ
5.03 ሚ
2.25 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
29.48 ሚ
34.92 ሚ
-26.07 ሚ
-66.57 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች